HomeCompareIGXT vs DIVO

IGXT vs DIVO: Dividend Comparison 2026

IGXT yields 1176.47% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IGXT wins by $78814195.17M in total portfolio value
10 years
IGXT
IGXT
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full IGXT calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — IGXT vs DIVO

📍 IGXT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIGXTDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IGXT + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IGXT pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IGXT
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, IGXT beats the other by $57,395,146,064,267.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IGXT + DIVO for your $10,000?

IGXT: 50%DIVO: 50%
100% DIVO50/50100% IGXT
Portfolio after 10yr
$39407097.62M
Annual income
$33,761,850,627,048.43/yr
Blended yield
85.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on IGXT right now

IGXT
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-23.8
Piotroski
4/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IGXT buys
0
DIVO buys
0
No recent congressional trades found for IGXT or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIGXTDIVO
Forward yield1176.47%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$78814195.20M$31.0K
Annual income after 10y$67,523,701,253,088.38$1,008.47
Total dividends collected$77969765.27M$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IGXT vs DIVO ($10,000, DRIP)

YearIGXT PortfolioIGXT Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$128,347$117,647.06$11,362$661.96+$117.0KIGXT
2$1,548,514$1,411,182.61$12,860$702.91+$1.54MIGXT
3$17,569,052$15,912,142.01$14,504$743.56+$17.55MIGXT
4$187,523,354$168,724,468.35$16,303$783.73+$187.51MIGXT
5$1,883,716,681$1,683,066,692.55$18,268$823.31+$1883.70MIGXT
6$17,816,329,317$15,800,752,468.33$20,408$862.17+$17816.31MIGXT
7$158,731,384,105$139,667,911,735.60$22,737$900.20+$158731.36MIGXT
8$1,332,782,916,056$1,162,940,335,063.89$25,266$937.31+$1332782.89MIGXT
9$10,551,863,503,163$9,125,785,782,982.70$28,008$973.42+$10551863.48MIGXT
10$78,814,195,201,473$67,523,701,253,088.38$30,977$1,008.47+$78814195.17MIGXT

IGXT vs DIVO: Complete Analysis 2026

IGXTStock

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Full IGXT Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this IGXT vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IGXT vs SCHDIGXT vs JEPIIGXT vs OIGXT vs KOIGXT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.